ERBB2 and breast cancer: αM induced apoptosis in breast cancer cells through the inhibition of fatty acid synthase via the signaling pathway of human epidermal growth factor receptor-2 (HER2)/phosphatidylinositide 3-kinase (PI3K)/Akt and mitogen-activated protein kinase (MAPK).